Yukiko Komeno Naoki Shibuya Hideki Uryu Haruki Yamada Takeo Toda Masayuki Shibasaki Shinji Kunishima Kuniko Iihara Tomiko Ryu
10.2169/internalmedicine.56.7258
Intern Med
2017;56(5):557-562.
CC BY-NC-ND
https://pubmed.ncbi.nlm.nih.gov/28250305/
Hemorrhage / etiology Lymphoma, B-Cell, Marginal Zone / complications Splenic Neoplasms / complications von Willebrand Diseases / etiology
Hemorrhage / etiology Lymphoma, B-Cell, Marginal Zone / complications Splenic Neoplasms / complications von Willebrand Diseases / etiology Case Reports Aged, 80 and over Antineoplastic Agents / therapeutic use Blood Coagulation Female Humans Lymphoma, B-Cell, Marginal Zone / diagnosis Lymphoma, B-Cell, Marginal Zone / drug therapy Partial Thromboplastin Time Rituximab / therapeutic use Splenectomy Splenic Diseases / etiology Splenic Neoplasms / diagnosis Splenic Neoplasms / drug therapy von Willebrand Diseases / diagnosis Antineoplastic Agents Rituximab
PMC5399210
28250305
Splenic Marginal Zone Lymphoma with Acquired von Willebrand Syndrome Diagnosed via Splenic Bleeding
2017